Adherence to risk management guidelines for drugs which cause vitamin D deficiency – big data from the Swedish health system
Authors:
Open Access
- 1 March 2019
- journal article
- research article
- Published by Taylor & Francis in Drug, Healthcare and Patient Safety
- Vol. ume 11, 19-28
Abstract
Purpose: Several medications are known to cause vitamin D deficiency. The aim of this study is to describe vitamin D testing and supplementation in patients using these “risk medications”, thereby assessing adherence to medical guidelines. Patients and methods: A database with electronic health records for the population in a Swedish County (≈240,000 inhabitants) was screened for patients prescribed the pre-defined “risk medications” during a 2-year period (2014–2015). In total, 12,194 patients were prescribed “risk medications” pertaining to one of the three included pharmaceutical groups. Vitamin D testing and concomitant vitamin D supplementation, including differences between the included pharmaceutical groups, was explored by matching personal identification numbers. Results: Corticosteroids were prescribed to 10,003 of the patients, antiepileptic drugs to 1,101, and drugs mainly reducing vitamin D uptake to 864. Two hundred twenty-six patients were prescribed >1 “risk medication”. Seven hundred eighty-seven patients (6.5%) had been tested during the 2-year period. There were no differences regarding testing frequency between groups. Concomitant supplements were prescribed to 3,911 patients (32.1%). It was more common to be prescribed supplements when treated with corticosteroids. Vitamin D supplementation was more common among tested patients in all three groups. Women were tested and supplemented to a higher extent. The mean vitamin D level was 69 nmol/L. Vitamin D deficiency was found in 24.1% of tested patients, while 41.3% had optimal levels. It was less common to be deficient and more common to have optimal levels among patients prescribed corticosteroids. Conclusion: Adherence to medical guidelines comprising testing and supplementation of patients prescribed drugs causing vitamin D deficiency needs improvement in Sweden.Keywords
This publication has 32 references indexed in Scilit:
- Vitamin D — Effects on Skeletal and Extraskeletal Health and the Need for SupplementationNutrients, 2013
- A Pooled Analysis of Vitamin D Dose Requirements for Fracture PreventionNew England Journal of Medicine, 2012
- Influence of drugs on vitamin D and calcium metabolismDermato-Endocrinology, 2012
- Association of Glucocorticoid Use and Low 25-Hydroxyvitamin D Levels: Results from the National Health and Nutrition Examination Survey (NHANES): 2001–2006The Journal of Clinical Endocrinology & Metabolism, 2011
- Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphataseAIDS, 2010
- Nonclassical Vitamin D ActionsNutrients, 2010
- Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin DAntiviral Therapy, 2009
- The Basophil Adenomas of the Pituitary Body and Their Clinical Manifestations (Pituitary Basophilism)1Obesity Research, 1994
- Bone mineral loss, bone histomorphometry and vitamin D metabolism in patients with rheumatoid arthritis on long-term glucocorticoid treatmentClinical Rheumatology, 1985
- Osteomalacia with Long-term Anticonvulsant Therapy in EpilepsyBMJ, 1970